ZERO WORLD RESEARCHLiterature database on amino acids & organic acids

Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.

Clinical lung cancer2020Hall PE, Ready N, Johnston A, et al.

Scholarly article — Clinical Trial, Phase II / Journal Article / Multicenter Study / Research Support, Non-U.S. Gov't

Study designOther literature / records
SubjectHuman

Record checks

Study design
Other literature / records
Subject
Human
Publication year
2020
Source
doi.org
Abstract display
Not reproduced here
Publication status
Active
Status checked
17 Aug 2026
Collected
13 Aug 2026
Freshness
Current
Review stage
Automated
Record status
Published

Abstract

The abstract is not reproduced here. Please consult the original source.

MeSH

AgedAged, 80 and overArginineCase-Control StudiesDrug Resistance, NeoplasmFemaleFollow-Up StudiesHumansHydrolasesLung NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalNon-Randomized Controlled Trials as TopicPolyethylene GlycolsPrognosisRetrospective StudiesSalvage TherapySmall Cell Lung Carcinoma

DOI 10.1016/j.cllc.2020.07.012

PMID 32859536

View source →